| 2025-12-18 | 2025 | Thomas E. Polen Chairman, | Chief Chief Executive Officer and President President | Founder / CEO | $1.40M | $0 | $9.99M | $3.31M | $1.85M | $577.95K | $17.13M |
| 2025-12-18 | 2025 | Christopher J. DelOrefice Executive | Vice Vice President President and Chief Chief Financial Officer | C-Level | $837.50K | $0 | $3.14M | $1.04M | $722.50K | $135.77K | $5.88M |
| 2025-12-18 | 2025 | Michael C. Feld Executive | Vice Vice President President, Chief Chief Revenue Officer and President President, Life Sciences Segment | C-Level | $775.00K | $0 | $1.64M | $544.12K | $533.59K | $602.05K | $4.10M |
| 2025-12-18 | 2025 | Michael D. Garrison Executive | Vice Vice President President and President President, Medical Essentials and BioPharma Systems Segments | C-Level | $768.75K | $0 | $1.64M | $544.12K | $533.59K | $160.99K | $3.65M |
| 2025-12-18 | 2025 | Richard E. Byrd Executive | Vice Vice President President and President President, Interventional Segment | C-Level | $756.25K | $0 | $1.43M | $473.14K | $592.88K | $149.26K | $3.40M |
| 2025-12-18 | 2024 | Thomas E. Polen Chairman, | Chief Chief Executive Officer and President President | Founder / CEO | $1.35M | $0 | $9.24M | $3.99M | $2.11M | $613.43K | $17.31M |
| 2025-12-18 | 2024 | Christopher J. DelOrefice Executive | Vice Vice President President and Chief Chief Financial Officer | C-Level | $785.40K | $0 | $2.69M | $1.16M | $906.40K | $85.58K | $5.63M |
| 2025-12-18 | 2024 | Michael D. Garrison Executive | Vice Vice President President and President President, Medical Essentials and BioPharma Systems Segments | C-Level | $731.25K | $0 | $1.51M | $653.45K | $556.20K | $168.08K | $3.62M |
| 2025-12-18 | 2024 | Richard E. Byrd Executive | Vice Vice President President and President President, Interventional Segment | C-Level | $681.25K | $0 | $1.18M | $508.25K | $648.90K | $253.56K | $3.27M |
| 2025-12-18 | 2023 | Thomas E. Polen Chairman, | Chief Chief Executive Officer and President President | Founder / CEO | $1.32M | $0 | $9.49M | $4.04M | $1.89M | $570.17K | $17.31M |
| 2025-12-18 | 2023 | Christopher J. DelOrefice Executive | Vice Vice President President and Chief Chief Financial Officer | C-Level | $736.20K | $0 | $2.53M | $1.08M | $774.97K | $85.45K | $5.21M |
| 2025-12-18 | 2023 | Michael D. Garrison Executive | Vice Vice President President and President President, Medical Essentials and BioPharma Systems Segments | C-Level | $675.00K | $0 | $1.28M | $547.13K | $599.57K | $548.17K | $3.65M |